Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1.

Sumanasekera C, Kelemen O, Beullens M, Aubol BE, Adams JA, Sunkara M, Morris A, Bollen M, Andreadis A, Stamm S.

Nucleic Acids Res. 2012 May;40(9):4025-39. doi: 10.1093/nar/gkr1289. Epub 2011 Dec 30.

2.

Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing.

Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME, Lorson CL, Lorson MA, Ben-Dov C, Fehlbaum P, Bracco L, Burghes AH, Bollen M, Stamm S.

Hum Mol Genet. 2008 Jan 1;17(1):52-70. Epub 2007 Oct 2.

PMID:
17913700
3.

De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.

Chalfant CE, Rathman K, Pinkerman RL, Wood RE, Obeid LM, Ogretmen B, Hannun YA.

J Biol Chem. 2002 Apr 12;277(15):12587-95. Epub 2002 Jan 18.

4.

Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells.

Ghosh N, Patel N, Jiang K, Watson JE, Cheng J, Chalfant CE, Cooper DR.

Endocrinology. 2007 Mar;148(3):1359-66. Epub 2006 Dec 7.

5.
6.

Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF.

Liu L, Xie N, Rennie P, Challis JR, Gleave M, Lye SJ, Dong X.

Mol Endocrinol. 2011 Jul;25(7):1197-210. doi: 10.1210/me.2010-0517. Epub 2011 May 12.

7.

Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA.

Zhang Z, Kelemen O, van Santen MA, Yelton SM, Wendlandt AE, Sviripa VM, Bollen M, Beullens M, Urlaub H, Lührmann R, Watt DS, Stamm S.

J Biol Chem. 2011 Mar 25;286(12):10126-36. doi: 10.1074/jbc.M110.183970. Epub 2011 Jan 10.

9.

Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.

Heyd F, Lynch KW.

Mol Cell. 2010 Oct 8;40(1):126-37. doi: 10.1016/j.molcel.2010.09.013.

10.

Identification of two RNA cis-elements that function to regulate the 5' splice site selection of Bcl-x pre-mRNA in response to ceramide.

Massiello A, Salas A, Pinkerman RL, Roddy P, Roesser JR, Chalfant CE.

J Biol Chem. 2004 Apr 16;279(16):15799-804. Epub 2004 Jan 20.

12.

DARPP-32 binds to tra2-beta1 and influences alternative splicing.

Benderska N, Becker K, Girault JA, Becker CM, Andreadis A, Stamm S.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):448-53. doi: 10.1016/j.bbagrm.2010.01.003. Epub 2010 Jan 13.

13.

Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.

Stoilov P, Daoud R, Nayler O, Stamm S.

Hum Mol Genet. 2004 Mar 1;13(5):509-24. Epub 2004 Jan 6.

PMID:
14709600
14.

Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.

Chang JG, Yang DM, Chang WH, Chow LP, Chan WL, Lin HH, Huang HD, Chang YS, Hung CH, Yang WK.

PLoS One. 2011;6(6):e18643. doi: 10.1371/journal.pone.0018643. Epub 2011 Jun 9.

15.

Regulation of alternative splicing within the supraspliceosome.

Sebbag-Sznajder N, Raitskin O, Angenitzki M, Sato TA, Sperling J, Sperling R.

J Struct Biol. 2012 Jan;177(1):152-9. doi: 10.1016/j.jsb.2011.11.005. Epub 2011 Nov 12.

16.

Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Mayeda A, Helfman DM, Krainer AR.

Mol Cell Biol. 1993 May;13(5):2993-3001. Erratum in: Mol Cell Biol 1993 Jul;13(7):4458.

17.

Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.

Hanamura A, Cáceres JF, Mayeda A, Franza BR Jr, Krainer AR.

RNA. 1998 Apr;4(4):430-44.

18.

Regulation of SRp20 exon 4 splicing.

Jumaa H, Nielsen PJ.

Biochim Biophys Acta. 2000 Nov 15;1494(1-2):137-43.

PMID:
11072076
20.

Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

Pilch B, Allemand E, Facompré M, Bailly C, Riou JF, Soret J, Tazi J.

Cancer Res. 2001 Sep 15;61(18):6876-84.

Supplemental Content

Support Center